How changes in Medicare reimbursement is facilitating the use of advanced diagnostic radiopharmaceuticals
The landscape of nuclear medicine and molecular imaging is undergoing significant transformation due to recent changes in reimbursement policies by the Centers for Medicare & Medicaid Services (CMS). These changes